Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02788370
Other study ID # PHD/0082/2556.1
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 26, 2016
Last updated August 17, 2017
Start date July 2016
Est. completion date December 2017

Study information

Verified date August 2017
Source Khon Kaen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim of this study is to compare cardiopulmonary response to conical-PEP breathing during exercise in older people.


Description:

It is known that all most structures and physiological functions deteriorate with age, leading to decrease exercise performance, functional decline and gradual decrease of physical activity in aging.

The most essential change of respiratory physiology are: dilatation of alveoli, enlargement of air space, decrease gas exchange surface area, loss of supporting tissue for distal airway (senile emphysema), decrees of chest wall compliance and decrease of respiratory muscle strength. These changes leading to decrease lung elastic recoil, increase residual volume and functional capacity, and increase work of breathing at rest. In addition, such changes affect respiratory function, especially dynamic hyperinflation (DH) development which could be one of the factors relate to dyspnea during exercise in aging Positive expiratory pressure (PEP) therapy for DH treatment during exercise was reported in several studies.

It is possible that PEP breathing may improve cardiopulmonary response to exercise in older people.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 12
Est. completion date December 2017
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria:

- Elder age between 60 to 80 years old with normal spirometry

Exclusion Criteria:

- They are diagnose with cardiovascular disease and, i.e. valvular heart disease, coronary heart disease, congenital heart disease, myocardial heart disease, uncontrolled hypertension, hyperlipidemia; or, present abnormal sign of heart problems previous month, such as chest pain, arrhythmia, abnormal ECG.

- They are impair balance from neuromuscular, musculoskeletal, or vestibular problem affecting cycling and walking.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
a conical positive expiratory pressure device
The CPEP device will be connected to respiratory transducer for generating positive expiratory pressure with therapeutic rang (5 to 20 cm H2O).
Other:
Constant work load cycling test
Participants will per form constant work load cycling test until symptom limit with 50 to 60 rpm. The termination criteria include sever breathlessness (>5 /10 score of modified Borg scale) leg fatigue (can not maintain speed between 50 to 60 rpm) Hear rate (HR) >80 % age-predicted maximum HR Exercise time up to 10 minutes Other symptom that stated by American thoracic Society(2002)

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Khon Kaen University Thailand Research Fund

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Inspiratory capacity (IC) Participants will be measured IC with slow vital capacity maneuver following American thoracic Society (ATS) and European Respiratory Society (ERS) statement for spirometry (2005). resting, immediate post exercise test and end recovery period of 10 minutes
Secondary Change of Slow vital capacity (SVC) Participants will be measured SVC with slow vital capacity maneuver following American thoracic Society (ATS) and European Respiratory Society (ERS) statement for spirometry (2005). resting, immediate post exercise test and end recovery period of 10 minutes
Secondary Change of respiratory rate (RR) The RR will be measured by a flow transducer of BioPAC system MP 36. The RR will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of hear rate (HR) Participants will be continuously recorded EKG by the BioPAC system MP 36 The HR will be collected from EKG. Moreover, real time EKG with HR will be measured by bedside monitor for termination criteria . Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of inspiratory time (Ti) The Ti will measure by a flow transducer of BioPAC system MP 36. The Ti will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of expiratory time (Te) The Te will measure by a flow transducer of BioPAC system MP 36. The Te will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of inspiratory and expiratory time ratio (IE ratio) The IE ratio will measure by a flow transducer of BioPAC system MP 36. The IE ratio will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of tidal volume (VT) The VT will measure by a flow transducer of BioPAC system MP 36. The VT will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of expiratory minute ventilation (VE) The VE will calculate from RR and VT and will present at resting, during exercise every minute, end exercise and every minute in recovery period for 10 minute Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of mean expiratory flow rate (MEF) The MEF will measure by a flow transducer of BioPAC system MP 36. The MEF will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of peak expiratory flow rate (PEF) The PEF will measure by a flow transducer of BioPAC system MP 36. The PEF will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of mean expiratory pressure (MEP) The MEP will measure by a pressure transducer of BioPAC system MP 36. The MEP will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of peak expiratory pressure (PEP) The PEP will measure by a pressure transducer of BioPAC system MP 36. The PEP will continuously measure throughout resting, during exercise, end exercise and recovery period fro 10 minute. Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of pule oxygen saturation (SpO2) Participants will be continuously measured SpO2 throughout the test. Researcher will collect SpO2 at resting, every minute during exercise, end exercise test and every minute of recovery period for 10 minutes. Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of end tidal carbon dioxide pressure (PetCO2) Participants will be continuously measured PetCO2 throughout the test. Researcher will collect PetCO2 at resting, every minute during exercise, end exercise test and every minute of recovery period for 10 minutes. Resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of rating perceive of breathlessness (RPB) Participant will rate RPB using a modified Borg dyspnea 10 scale at resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes. resting, during exercise every minute, end exercise test and every minute of recovery period for 10 minutes
Secondary Change of leg fatigue Participant will rate their leg fatigue using a visual analog scale at resting, end exercise test and end recovery period for 10 minutes. resting, , end exercise test and end recovery period
Secondary Change of systolic blood pressure (SBP) The SBP will be measured by a bedside monitor at resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes. resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes
Secondary Change of diastolic blood pressure (DBP) The SBP will be measured by a bedside monitor at resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes. resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes
Secondary Change of mean arterial pressure (MAP) The MAP will be measured by a bedside monitor at resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes. resting, immediate post exercise test and every 2 minutes during recovery period for 10 minutes
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A